01.10.2022 | Case report
Adalimumab/duloxetine/ustekinumab
Hheart failure with reduced ejection fraction, non-ischaemic dilated cardiomyopathy and loss of response: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2022
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event